Ludovica V. Marfella

Naples, 80138, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

Diet-Induced Ceramide Remodeling as a Mechanistic Link to Cardiac Metabolic Dysfunction.

Diet-Induced Ceramide Remodeling as a Mechanistic Link to Cardiac Metabolic Dysfunction.

Journal: Nutrients

Published: June 03, 2026

Microplastics in human lung tissue from autopsy samples collected in 1991 and 2024: a comparative post-mortem study.

Microplastics in human lung tissue from autopsy samples collected in 1991 and 2024: a comparative post-mortem study.

Journal: The Lancet regional health. Europe

Published: March 24, 2026

Analytical techniques for detecting micro- and nanoplastics in blood and vascular tissues: Strengths and limitations.

Analytical techniques for detecting micro- and nanoplastics in blood and vascular tissues: Strengths and limitations.

Journal: Kardiologia polska

Published: February 04, 2026

Microplastics and Atherosclerosis: Mechanisms.

Microplastics and Atherosclerosis: Mechanisms.

Journal: Annual review of pharmacology and toxicology

Published: January 23, 2026

Detection and Proinflammatory Effects of BTEX within the Human Atherosclerotic Plaque.

Detection and Proinflammatory Effects of BTEX within the Human Atherosclerotic Plaque.

Journal: Environmental science & technology

Published: December 11, 2025

Environmental Pollutant-Induced Cardiopathogenesis Through Immune Dysfunction: The Emerging Role of Micro- and Nanoplastics.

Environmental Pollutant-Induced Cardiopathogenesis Through Immune Dysfunction: The Emerging Role of Micro- and Nanoplastics.

Journal: The Canadian journal of cardiology

Published: December 02, 2025

Cardioprotective mechanism of ω-3 fatty acid icosapent ethyl (IPE) in cardiomyocytes: role in high glucose and shear stress-induced mechano-transduction dysregulation.

Cardioprotective mechanism of ω-3 fatty acid icosapent ethyl (IPE) in cardiomyocytes: role in high glucose and shear stress-induced mechano-transduction dysregulation.

Journal: Cardiovascular diabetology

Published: October 08, 2025

GLP-1 Receptor Agonists Are Associated with Reduced Ascending Aorta Dilatation in Patients with Type 2 Diabetes: A Prospective Study.

GLP-1 Receptor Agonists Are Associated with Reduced Ascending Aorta Dilatation in Patients with Type 2 Diabetes: A Prospective Study.

Journal: International journal of molecular sciences

Published: September 15, 2025

Intra-plaque vascularization assessed in contrast-enhanced ultrasound predicts cardiovascular events in type 2 diabetes with no significant carotid atherosclerotic stenosis: a prospective study with therapeutic implications for SGLT2 inhibitor use.

Intra-plaque vascularization assessed in contrast-enhanced ultrasound predicts cardiovascular events in type 2 diabetes with no significant carotid atherosclerotic stenosis: a prospective study with therapeutic implications for SGLT2 inhibitor use.

Journal: European heart journal. Imaging methods and practice

Published: August 21, 2025

Endothelial dysfunction and cardiovascular outcomes in pre-menopausal women with high vs low breast fat accumulation: The role of TSP-1.

Endothelial dysfunction and cardiovascular outcomes in pre-menopausal women with high vs low breast fat accumulation: The role of TSP-1.

Journal: American journal of preventive cardiology

Published: July 29, 2025

Effects of combination therapy with SGLT2 inhibitors and GLP-1 receptor agonists on CRT response and clinical outcomes in in type 2 diabetes mellitus patients receiving chronic anti-diabetic medications: A multicenter observational study.

Effects of combination therapy with SGLT2 inhibitors and GLP-1 receptor agonists on CRT response and clinical outcomes in in type 2 diabetes mellitus patients receiving chronic anti-diabetic medications: A multicenter observational study.

Journal: Diabetes research and clinical practice

Published: June 26, 2025

Vericiguat for endothelial dysfunction and CRT response in non-responders: the VERCET prospective observational study.

Vericiguat for endothelial dysfunction and CRT response in non-responders: the VERCET prospective observational study.

Journal: BMC medicine

Published: June 11, 2025

Showing 1-12 of 19

Last Updated: 09/26/2026